a nonsignificant trendp = 0.08
There was a nonsignificant trend towards an increased use of thiopurines (56.3% vs. 35.8%, p = 0.08) and biologics (32.6% vs. 25.1%, p = 0.06) in the CD group compared to the UC/IBDU group. 3.3.
There was a nonsignificant trend towards an increased use of thiopurines (56.3% vs. 35.8%, p = 0.08) and biologics (32.6% vs. 25.1%, p = 0.06) in the CD group compared to the UC/IBDU group. 3.3.